These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. Hochman D; Wolff B JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763 [No Abstract] [Full Text] [Related]
7. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. Callegari PE; Schaible TF; Boscia JA JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762 [No Abstract] [Full Text] [Related]
8. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. Costenbader KH; Glass R; Cui J; Shadick N JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761 [No Abstract] [Full Text] [Related]
9. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [TBL] [Abstract][Full Text] [Related]
10. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. Okada SK; Siegel JN JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760 [No Abstract] [Full Text] [Related]
11. Safety of rituximab in rheumatoid arthritis patients with a history of severe or recurrent bacterial infection: observational study of 30 cases in everyday practice. Toussirot E; Pertuiset E; Sordet C; Augé B; Wendling D; Pallot-Pradès B; Collet P; Lohse A; Balblanc JC Joint Bone Spine; 2010 Mar; 77(2):142-5. PubMed ID: 20171921 [TBL] [Abstract][Full Text] [Related]
12. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. den Broeder AA; Creemers MC; Fransen J; de Jong E; de Rooij DJ; Wymenga A; de Waal-Malefijt M; van den Hoogen FH J Rheumatol; 2007 Apr; 34(4):689-95. PubMed ID: 17117492 [TBL] [Abstract][Full Text] [Related]
13. Association of infections and tuberculosis with antitumor necrosis factor alpha therapy. Patkar NM; Teng GG; Curtis JR; Saag KG Curr Opin Rheumatol; 2008 May; 20(3):320-6. PubMed ID: 18388525 [TBL] [Abstract][Full Text] [Related]
14. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Wolfe F; Caplan L; Michaud K Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Schneeweiss S; Setoguchi S; Weinblatt ME; Katz JN; Avorn J; Sax PE; Levin R; Solomon DH Arthritis Rheum; 2007 Jun; 56(6):1754-64. PubMed ID: 17530704 [TBL] [Abstract][Full Text] [Related]
17. Risk of tuberculosis in patients with rheumatoid arthritis in Hong Kong--the role of TNF blockers in an area of high tuberculosis burden. Tam LS; Leung CC; Ying SK; Lee GK; Yim CW; Leung YY; Kun EW; Wong KK; Li EK Clin Exp Rheumatol; 2010; 28(5):679-85. PubMed ID: 20822708 [TBL] [Abstract][Full Text] [Related]
18. Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry. Gottenberg JE; Ravaud P; Bardin T; Cacoub P; Cantagrel A; Combe B; Dougados M; Flipo RM; Godeau B; Guillevin L; Le Loët X; Hachulla E; Schaeverbeke T; Sibilia J; Baron G; Mariette X; Arthritis Rheum; 2010 Sep; 62(9):2625-32. PubMed ID: 20506353 [TBL] [Abstract][Full Text] [Related]
19. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. Komano Y; Tanaka M; Nanki T; Koike R; Sakai R; Kameda H; Nakajima A; Saito K; Takeno M; Atsumi T; Tohma S; Ito S; Tamura N; Fujii T; Sawada T; Ida H; Hashiramoto A; Koike T; Ishigatsubo Y; Eguchi K; Tanaka Y; Takeuchi T; Miyasaka N; Harigai M; J Rheumatol; 2011 Jul; 38(7):1258-64. PubMed ID: 21498482 [TBL] [Abstract][Full Text] [Related]
20. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Kroesen S; Widmer AF; Tyndall A; Hasler P Rheumatology (Oxford); 2003 May; 42(5):617-21. PubMed ID: 12709536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]